Back to Neurology
Neurologyv2015Evidence-Based

Modified SOAR Score for Stroke

Predicts short-term mortality in acute stroke by adding NIHSS score to the original SOAR criteria, improving prognostic accuracy while maintaining clinical practicality.

Clinical Input Parameters

points
Range: 0 — 42 points
Clinical Assessment
Awaiting Parameters
msoar score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Modified SOAR Score for Stroke is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

mSOAR Score = Age points (0-2) + Stroke subtype points (0-1) + Oxfordshire classification points (0-2) + Pre-stroke mRS points (0-2) + NIHSS points (0-2). Range: 0-9 points.

Clinical Pearls & Practice Notes

  • Modified version adds NIHSS score to improve prognostic accuracy over original SOAR
  • Area under ROC curve improved from 0.79 (SOAR) to 0.83 (mSOAR)
  • Validates for predicting early mortality, length of stay, and discharge disability
  • Simple bedside tool using easily accessible clinical information
  • External validation shows AUC of 0.84 for early mortality prediction
  • Mortality risk ranges from 3% (score 0-2) to >35% (score 7-9)
  • Useful for clinical decision-making and family communication regarding prognosis

Evidence & Literature Citations

  1. Myint PK, Clark AB, Kwok CS, Loke YK, Yeong JK, Luben RN, et al. The SOAR (Stroke subtype, Oxford Community Stroke Project classification, Age, prestroke modified Rankin) score strongly predicts early outcomes in acute stroke. Int J Stroke. 2014;9(3):278-83. doi: 10.1111/ijs.12088.
  2. Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, et al. Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol. 2015;22(8):1048-55. doi: 10.1111/ene.12577.
  3. Myint PK, Clark AB, Kwok CS, Loke YK, Yeong JK, Luben RN, et al. Derivation and Validation of a Novel Prognostic Scale (Modified-Stroke Subtype, Oxfordshire Community Stroke Project Classification, Age, and Prestroke Modified Rankin) to Predict Early Mortality in Acute Stroke. J Am Heart Assoc. 2015;4(12):e002652. doi: 10.1161/JAHA.115.002652.

Score Interpretation Ranges

Low Risk0 – 2 pts

3-7% early mortality risk

Moderate Risk3 – 4 pts

8-20% early mortality risk

High Risk5 – 6 pts

21-35% early mortality risk

Very High Risk7 – 9 pts

>35% early mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.